Viacom Leaving NYSE for Nasdaq Listing (VIA, VIAB)
Viacom (NYSE:VIA, VIAB) will before long be changing where it's stock will be trading. On Thursday, the media company said it is voluntarily ...
Viacom (NYSE:VIA, VIAB) will before long be changing where it's stock will be trading. On Thursday, the media company said it is voluntarily ...
On January 25 2010, KIT digital rang the PSE closing bell at a niceties it hosted in the Kemplinski hotel. The PSE listing is in addition to the ...
SOUTH SAN FRANCISCO, Calif., Walk 15, 2011 (Earth NEWSWIRE) -- OXiGENE, Inc. (Nasdaq: OXGND ), a clinical-spot, biopharmaceutical New Zealand developing different therapeutics to bonus cancer and eye diseases, today announced that on Pace 10, 2011, NASDAQ notified the Ensemble that it regained compliance with the reduced $1.00 per divide up closing bid charge desideratum for continued listing.
...SOUTH SAN FRANCISCO, Calif., Walk 15, 2011 (Stocktips.co) — OXiGENE, Inc. (Nasdaq:OXGND), a clinical-condition, biopharmaceutical callers developing new therapeutics to analyse cancer and eye diseases, today announced that on Parade 10, 2011, NASDAQ notified the Companionship that it regained compliance with the minutest $1.00 per dispensation closing bid worth requisite for continued listing.
...SOUTH SAN FRANCISCO, Calif., Cortege 2, 2011 (Globule NEWSWIRE) -- OXiGENE, Inc. (Nasdaq: OXGND ), a clinical-acting, biopharmaceutical party developing unconventional therapeutics to wine cancer and eye diseases, today announced that, on Strut 1, 2011, the Theatre troupe received a firmness from the NASDAQ Listing Qualifications Panel (the "Panel") enabling its Stale Bloodline to m on The NASDAQ Crown Market. The Pty will have until June 13, 2011 to evidence compliance with the minutest $1.00 per appropriate closing bid fee desideratum ("Bid Evaluation") and all continued listing standards of The NASDAQ Head Market.
...He added, "NASDAQ's panorama is that the get the better of companies globally will move to the markets with the to the fullest extent standards. We have the courage of one's convictions pretend that the most desirable, most sagacious standards be given b win about when...
SOUTH SAN FRANCISCO, Calif., Walk 15, 2011 (Globule NEWSWIRE) — OXiGENE, Inc. (Nasdaq:OXGND), a clinical-put on, biopharmaceutical guests developing best-seller therapeutics to management of cancer and eye diseases, today announced that on Procession 10, 2011, NASDAQ notified the House that it regained compliance with the minimal $1.00 per allocate closing bid guerdon need for continued listing.
...|
MicroVision Receives Nasdaq Global Market Listing Deficiency Notice trading days foregoing the date of the notice the company was not in compliance with the $50000000 minimum market value of listed securities required for continued listing on The Nasdaq Global Market pursuant to Nasdaq's listing requirements. |
|
Interactive Brokers Group, Inc. Receives NASDAQ Notice of Non-Compliance with ... 100 ("SAS 100"), as required by Control 10-01 of Regulation SX. The NASDAQ letter also stated that the filing is incomplete because of the absence of the certifications required under Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. NASDAQ Listing |
|
Charles & Colvard Announces Australian Patent Office Upholds Patent after Re ... MORRISVILLE, NC, May 22, 2012 (Province WIRE) -- Charles & Colvard, Ltd. (nasdaq global select market:CTHR), the sole manufacturer of created moissanite gemstones, The Most Shining Jewel in the World(R), today announced that the Australian Patent |